At BioGenes, we elevate immunogenicity testing with dual-step affinity chromatography, isolating specific anti-idiotypic (anti-ID) antibodies while depleting human IgGs.
Why it matters?
✅ Enhanced Specificity: Only relevant anti-ID antibodies remain
✅ Reduced Background: Minimizes false positives for reliable ELISA results
✅ Improved Quantification: Accurate ADA measurement for biopharma monitoring
Our process delivers two high-purity fractions and undergoes strict ELISA quality control, powering soluble bridging assays with exceptional sensitivity.
Precision and innovation drive our solutions for biopharma needs.
News
BioGenes Berlin
Our Affinity Purification Strategy
